Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat-containing protein 46 (WDR46) is a nucleolar scaffold protein that is essential for the spatial organization of ribosomal RNA (rRNA) processing machinery within the nucleolus[1][3][5][6][8]. It is a core part of the small-subunit (SSU) processome, which is responsible for biogenesis of the small ribosomal subunit[3][9]. WDR46 interacts with key proteins such as nucleolin and DDX21, facilitating their correct compartmental localization within the nucleolus[1][5][6][8]. The protein is characterized by WD40 repeats, forming a β-propeller structure typical of this large protein family, which generally function as molecular scaffolds for complex assembly without enzymatic or receptor activity[2][4]. There is currently no evidence that WDR46 has enzymatic function or serves directly as a therapeutic target. WDR46 has been weakly associated with certain conditions such as aspirin intolerance with nasal polyps and asthma, but these roles are associative rather than therapeutic or causal[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat-containing protein 46 (WDR46).